Skip to main content

Integración de nuevos métodos NGS y de interactómica en el diagnóstico de leucodistrofias

FJCI-2016-28811

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Formación
Call Juan de la Cierva Formación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACIO INSTITUT D INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia

  • Verdura, Edgard
  • Font, Carme
  • Schlüter, Agatha
  • Ruiz, Montserrat
  • Fourcade, Stéphane
  • Casasnovas, Carlos
  • Castellano, Antonio
  • Pujol, Aurora
[Background] Since 1994, over 50 families affected by the episodic ataxia type 1 disease spectrum have been described with mutations in KCNA1, encoding the voltage-gated K+ channel subunit Kv1.1. All of these mutations are either transmitted in an autosomal-dominant mode or found as de novo events., [Methods] A patient presenting with a severe combination of dyskinesia and neonatal epileptic encephalopathy was sequenced by whole-exome sequencing (WES). A candidate variant was tested using cellular assays and patch-clamp recordings., [Results] WES revealed a homozygous variant (p.Val368Leu) in KCNA1, involving a conserved residue in the pore domain, close to the selectivity signature sequence for K+ ions (TVGYG). Functional analysis showed that mutant protein alone failed to produce functional channels in homozygous state, while coexpression with wild-type produced no effects on K+ currents, similar to wild-type protein alone. Treatment with oxcarbazepine, a sodium channel blocker, proved effective in controlling seizures., [Conclusion] This newly identified variant is the first to be reported to act in a recessive mode of inheritance in KCNA1. These findings serve as a cautionary tale for the diagnosis of channelopathies, in which an unreported phenotypic presentation or mode of inheritance for the variant of interest can hinder the identification of causative variants and adequate treatment choice., This study was supported by the Centre for Biomedical Research on Rare Diseases (CIBERER) (ACCI14-759), the URDCat program (PERIS SLT002/16/00174), the Hesperia Foundation and the Secretariat for Universities and Research of the Ministry of Business and Knowledge of the Government of Catalonia (2017SGR1206) to AP and Instituto de Salud Carlos III (PI14/00581) (cofunded by European Regional Development Fund. ERDF, a way to build Europe) and la Marató de TV3 (345/C/2014) to CC and AP. EV was funded by a grant from the Ministerio de Economia, Industria y Competividad (Juan de la Cierva programme FJCI-2016-28811). SF was funded by the Instituto de Salud Carlos III (Miguel Servet programme CPII16/00016, cofunded by European Social Fund. ESF investing in your future) and MR was funded by CIBERER., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A novel hypomorphic splice variant in EIF2B5 gene is associated with mild ovarioleukodystrophy

  • Rodríguez-Palmero, Agustí|||0000-0002-4141-5515
  • Schlüter, Agatha|||0000-0001-6732-1528
  • Verdura, Edgard|||0000-0003-3856-2060
  • Ruiz, Montserrat|||0000-0003-0466-2653
  • Martínez, Juan José
  • Gourlaouen, Isabelle
  • Ka, Chandran
  • Lobato, Ricardo
  • Casasnovas, Carlos|||0000-0002-7933-4681
  • Le Gac, Gérald|||0000-0003-3236-7280
  • Fourcade, Stéphane|||0000-0002-8031-5007
  • Pujol, Aurora|||0000-0002-9606-0600
To identify the genetic cause in an adult ovarioleukodystrophy patient resistant to diagnosis. We applied whole-exome sequencing (WES) to a vanishing white matter disease patient associated with premature ovarian failure at 26 years of age. We functionally tested an intronic variant by RT-PCR on patient's peripheral blood mononuclear cells (PBMC) and by minigene splicing assay. WES analysis identified two novel variants in the EIF2B5 gene: c.725A.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Loss of seryl-tRNA synthetase (SARS1) causes complex spastic paraplegia and cellular senescence

  • Verdura, Edgard|||0000-0003-3856-2060
  • Senger, Bruno
  • Raspall-Chaure, Miquel|||0000-0002-3132-3342
  • Schlüter, Agatha|||0000-0001-6732-1528
  • Launay, Nathalie|||0000-0002-7498-217X
  • Ruiz, Montserrat|||0000-0003-0466-2653
  • Casasnovas, Carlos|||0000-0002-7933-4681
  • Rodríguez-Palmero, Agustí|||0000-0002-4141-5515
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Becker, Hubert Dominique
  • Pujol, Aurora|||0000-0002-9606-0600
Aminoacyl-tRNA synthetases (ARS) are key enzymes catalysing the first reactions in protein synthesis, with increasingly recognised pleiotropic roles in tumourgenesis, angiogenesis, immune response and lifespan. Germline mutations in several ARS genes have been associated with both recessive and dominant neurological diseases. Recently, patients affected with microcephaly, intellectual disability and ataxia harbouring biallelic variants in the seryl-tRNA synthetase encoded by seryl-tRNA synthetase 1 (SARS1) were reported. We used exome sequencing to identify the causal variant in a patient affected by complex spastic paraplegia with ataxia, intellectual disability, developmental delay and seizures, but without microcephaly. Complementation and serylation assays using patient's fibroblasts and an Saccharomyces cerevisiae model were performed to examine this variant's pathogenicity. A de novo splice site deletion in SARS1 was identified in our patient, resulting in a 5-amino acid in-frame insertion near its active site. Complementation assays in S. cerevisiae and serylation assays in both yeast strains and patient fibroblasts proved a loss-of-function, dominant negative effect. Fibroblasts showed an abnormal cell shape, arrested division and increased beta-galactosidase staining along with a senescence-associated secretory phenotype (raised interleukin-6, p21, p16 and p53 levels). We refine the phenotypic spectrum and modes of inheritance of a newly described, ultrarare neurodevelopmental disorder, while unveiling the role of SARS1 as a regulator of cell growth, division and senescence